Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
33143745
Public Release Type:
Journal
Publication Year: 2020
DOI:
https://doi.org/10.1186/s12916-020-01769-6
Authors:
Andlauer Till F. M., Link Jenny, Martin Dorothea, Ryner Malin, Hermanrud Christina, Grummel Verena, Auer Michael, Hegen Harald, Aly Lilian, Gasperi Christiane, Knier Benjamin, Müller-Myhsok Bertram, Jensen Poul Erik Hyldgaard, Sellebjerg Finn, Kockum Ingrid, Olsson Tomas, Pallardy Marc, Spindeldreher Sebastian, Deisenhammer Florian, Fogdell-Hahn Anna, Hemmer Bernhard
Request IDs:
22447
Studies:
T1DGC HLA Reference Panel for Imputation with SNP2HLA
Upon treatment with biopharmaceuticals, the immune system may produce anti-drug antibodies (ADA) that inhibit the therapy. Up to 40% of multiple sclerosis patients treated with interferon β (IFNβ) develop ADA, for which a genetic predisposition exists. Here, we present a genome-wide association study on ADA and predict the occurrence of antibodies in multiple sclerosis patients treated with different interferon β preparations.
